BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21317934)

  • 21. Donor lymphocyte infusion may reduce the incidence of bronchiolitis obliterans after allogeneic stem cell transplantation.
    Forslöw U; Mattsson J; Gustafsson T; Remberger M
    Biol Blood Marrow Transplant; 2011 Aug; 17(8):1214-21. PubMed ID: 21193056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Azithromycin for the Treatment of Obliterative Bronchiolitis after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Yadav H; Peters SG; Keogh KA; Hogan WJ; Erwin PJ; West CP; Kennedy CC
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2264-2269. PubMed ID: 27575542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection.
    Federica M; Nadia S; Monica M; Alessandro C; Tiberio O; Francesco B; Mario V; Maria FA
    Clin Transplant; 2011; 25(4):E381-9. PubMed ID: 21418327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Azithromycin improves lung function in patients with post-lung transplant bronchiolitis obliterans syndrome: a meta-analysis.
    Kingah PL; Muma G; Soubani A
    Clin Transplant; 2014 Aug; 28(8):906-10. PubMed ID: 24931185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?
    Verleden GM; Dupont LJ; Van Raemdonck DE
    Eur Respir J; 2005 Feb; 25(2):221-4. PubMed ID: 15684284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection.
    Vos R; Vanaudenaerde BM; Verleden SE; Ruttens D; Vaneylen A; Van Raemdonck DE; Dupont LJ; Verleden GM
    Transplantation; 2012 Jul; 94(2):101-9. PubMed ID: 22461039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effect of azithromycin in bronchiolitis obliterans syndrome.
    Gan CT; Ward C; Meachery G; Lordan JL; Fisher AJ; Corris PA
    BMJ Open Respir Res; 2019; 6(1):e000465. PubMed ID: 31673366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
    J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Kim SW; Rhee CK; Kim YJ; Lee S; Kim HJ; Lee JW
    Respir Res; 2016 May; 17(1):63. PubMed ID: 27229850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of the therapeutic potential of the cysteinyl leukotriene antagonist Montelukast in the treatment of bronchiolitis obliterans syndrome following lung and hematopoietic-stem cell transplantation and its possible mechanisms.
    Kordjazy N; Amini S
    Ther Adv Respir Dis; 2024; 18():17534666241232284. PubMed ID: 38504551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Home spirometry as early detector of azithromycin refractory bronchiolitis obliterans syndrome in lung transplant recipients.
    de Wall C; Sabine D; Gregor W; Mark G; Axel H; Thomas F; Tobias W; Jens G
    Respir Med; 2014 Feb; 108(2):405-12. PubMed ID: 24445061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of Bronchiolitis Obliterans Syndrome Using Nitrogen Multiple Breath Washout in Children Posthemopoietic Stem Cell Transplant.
    Westrupp N; Berry CD; Cole T; Shanthikumar S; Welsh L
    Transplant Cell Ther; 2024 May; 30(5):524.e1-524.e9. PubMed ID: 38360272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of prophylactic azithromycin on bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Jo KW; Yoon S; Song JW; Shim TS; Lee SW; Lee JS; Kim DY; Lee JH; Lee JH; Choi Y; Lee KH
    Int J Hematol; 2015 Sep; 102(3):357-63. PubMed ID: 26121954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late pulmonary complications after allogeneic hematopoietic stem cell transplantation: diagnosis, monitoring, prevention, and treatment.
    Bacigalupo A; Chien J; Barisione G; Pavletic S
    Semin Hematol; 2012 Jan; 49(1):15-24. PubMed ID: 22221781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial.
    Ruttens D; Verleden SE; Demeyer H; Van Raemdonck DE; Yserbyt J; Dupont LJ; Vanaudenaerde BM; Vos R; Verleden GM
    PLoS One; 2018; 13(4):e0193564. PubMed ID: 29624575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Azithromycin as a novel treatment for bronchiolitis obliterans syndrome].
    Peled N; Shitrit D; Bendayan D; Kramer MR
    Harefuah; 2007 Mar; 146(3):219-22, 245. PubMed ID: 17460931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Rituximab on Pulmonary Function in Bronchiolitis Obliterans Syndrome due to Graft-Versus-Host-Disease.
    Brownback KR; Thomas LA; McGuirk JP; Ganguly S; Streiler C; Abhyankar S
    Lung; 2017 Dec; 195(6):781-788. PubMed ID: 28894914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of inhaled fluticasone propionate on BAL TGF-beta(1) and bFGF concentrations in clinically stable lung transplant recipients.
    Zheng L; Walters EH; Wang N; Whitford H; Orsida B; Levvey B; Bailey M; Williams TJ; Snell GI
    J Heart Lung Transplant; 2004 Apr; 23(4):446-55. PubMed ID: 15063404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic role of FEV1 for survival in bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.
    Ahn JH; Jo KW; Song JW; Shim TS; Lee SW; Lee JS; Kim DY; Lee JH; Lee JH; Choi Y; Lee KH
    Clin Transplant; 2015 Dec; 29(12):1133-9. PubMed ID: 26383085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation.
    Nakane T; Nakamae H; Kamoi H; Koh H; Takeoka Y; Sakamoto E; Kanashima H; Nakamae M; Ohta K; Terada Y; Koh KR; Yamane T; Hino M
    Bone Marrow Transplant; 2008 Jul; 42(1):43-9. PubMed ID: 18347569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.